Risk factors associated with the presence of antibodies to Borrelia burgdorferi;Factores de riesgo asociados con la presencia de anticuerpos contra Borrelia burgdorferi

Revista Clinica Espanola

Volumn 199, Issue 3, 1999, Pages 136-141

  Arteaga Perez F ^a   Garcia Monco Carra J C ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Borrelia burgdorferi; Borreliosis; Lyme; Serology; Seroprevalence

Indexed keywords

BACTERIUM ANTIBODY;

ARTICLE; BLOOD; BORRELIA BURGDORFERI; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; HUMAN; IMMUNOLOGY; LYME DISEASE; MIDDLE AGED; OCCUPATIONAL DISEASE; RISK FACTOR; SPAIN;

ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI GROUP; CROSS-SECTIONAL STUDIES; HUMANS; LYME DISEASE; MIDDLE AGED; OCCUPATIONAL DISEASES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

EID: 0345921893     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Steere AC. Lyme disease. N Engl J Med 1989; 321:586-596.
2. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grundwaldt E, Davis JP. Lyme disease a tick-borne spirochetosis? Science 1982; 216:1.317-1.319.
3. Sáez S, Sánchez Covisa A, Guerrero Espejo A. Garrapatas y enfermedad de Lyme. Enferm Infecc Microbiol Clin 1991; 9:111-115.
4. Oteo JA, Estrada-Peña A. Ixodes ricinus. vector comprobado de Borrelia burgdorferi en España. Med Clin (Barc) 1991; 96:599.
5. Matuschka FR, Fischer P, Heiler M, Blümcke S, Spielman A. Stage-associated risk of transmission of the Lyme disease spirochete by European Ixodes ticks. Parasitol Res 1992; 78:695-698.
6. Saz JV, Merino FJ, Beltrán M. Enfermedad de Lyme en España: aspectos clínicos y epidemiológicos. Rev Clin Esp 1995; 195:44-49.
7. Oteo JA, Martínez de Artola V. Borreliosis de Lyme: aspectos epidemiológicos y etiopatogénicos. Enferm Infecc Microbiol Clin 1995; 13:550-555.
8. Steere AC, Broderick TF, Malawista SE, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children an adults in three Connecticut communities. Arthritis Rheum 1977; 20:7-17.
9. Buchwald A. Ein fall von diffuser diopathischer Haut-Atrophie. Derm Vierteljaresschr 1883; 533-556.
10. Afzelius A. Verhandlungen der dermatogischen gesellschaft ru Stockolm on october 28, 1909. Arch Dermatol Syph 1910; 101-404.
11. Lipschütz B. Über eine seltene Erythemform (Erythema chronicum migrans). Arch Dermatol Syph (Berlín) 1913; 118:349-356.
12. Garin C, Bujadoux C. Paralyse par les tiques. J Med Lyon 1922; 71:765-767.
13. Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und rheumatismus. Ein beitrag zum problem allergie und nerven system. Arch Psychiatr Nervenk 1941; 113:284-376.
14. Uruñuela S, Díaz D. Eritema crónica migrans. Actas Dermosifilogr 1977; 68:109-110.
15. Uría DF, Calatayud M, Mongelos JM, Miguel MD, Cobos A, Suárez T. Meningopolineuritis como manifestatión de la enfermedad de Lyme. Med Clín (Barc) 1987; 89:381-383.
16. Tamayo L, García-Moncó JC, Bratos MA, Orduña A, Ortiz de Lejarazu R, Rodriguez Torres A. Anticuerpos frente a Borrelia burgdorferi en un grupo de poblacion de Valladolid. Enferm Infecc Microbiol Clin 1990; 8:663-664.
17. Guerrero A, Serrano MJ y Grupo de Estudio para la Enfermedad de Lyme en España. Frecuencia y espectro clínico de la infección por Borrelia burgdorferi en España. Med Clín (Barc) 1989; 92:438-439.
18. Formento JA, Isanta C, Domínguez JL, Arenas A. Enfermedad de Lyme oligosintomática. Diagnóstico en Atención Primaria. Enf Infec Microbiol Clin 1992; 10:176.
19. Benito-Urbina S, Elena A, Castañares MJ, Lantero M. Enfermedad de Lyme en La Rioja. Med Clín (Barc) 1990; 95:598.
20. Oteo Revuelta JA, Martínez de Artola V, Gómez-Cadiñanos R, Casas Fernández-Tejerina JM, Grandival García R. Eritema crónico migratorio (enfermedad de Lyme). Estudio clínico-epidemiológico de 10 casos. Rev Clín Esp 1993; 193:20-23.
21. Guerrero A. La enfermedad de Lyme en España. Med Clín (Barc) 1992; 98:96-97.
22. García-Moncó JC, Benach JL, Coleman JL, et al. Caracterización de una cepa española de Borrelia burgdorferi. Med Clin (Barc) 1992; 98:89-93.
23. Schmid GP. The global distribution of Lyme disease. Rev Infect Dis 1985; 7:41-50.
24. Anda P, Rodríguez Y, De la Loma A, Fernández MV, Lozano A. A serological survey and review of clinical Lyme borreliosis in Spain. Clin Infect Dis 1993; 16:310-319.
25. Barral M. Especies de garrapatas presentes en la vegetación de la Comunidad Autónoma Vasca. Informe técnico n. ° 54, 1993. Departamento de Agricultura y Pesca y Departamento de Sanidad del País Vasco.
26. Arteaga F, García-Moncó JC. Asociación de la enfermedad de Lyme con actividades laborales y de recreo. Enf Inf Microbiol Clin 1998; 16:265-268.
27. Guerrero A, Escudero R, Martí-Belda P, Quereda C. Frecuencia de las manifestaciones clinicas de la borreliosis de Lyme en España. Enferm Infecc Microbiol Clin 1996; 2:72-79.
28. Rodríguez Torres A, Miranda A, Quiñones PA, Pérez Oliva N, Bratos MA, Orduña A, Crespo Pinilla J. Eritema crónica migratorio por Borrelia burgdorferi. Med Clín (Barc) 1988; 91:297-299.
29. Gómez-Mateos JM, Sánchez-Porto A, Lozano de Léon F, López-Cortés L. Enfermedad de Lyme en la provincia de Sevilla. Med Clín (Barc) 1990; 94:236-2.347.
30. Oteo JA, Martínez de Artola V, Fernández Calvo JL, Casas JM, Rivero A, Grandival R. Prevalencia de anticuerpos frente a Borrelia burgdorferi en una población de riesgo. Rev Clín Esp 1990; 187:215-217.
31. Oteo JA, Casas JM, Martínez de Artola V. Lyme disease in outdoor workers: risk factors, preventive measures, and tick removal methods. Am J Epidemiol 1991; 133:754-755.
32. Carranza R, Borobio MV, Pascual F, Perea EJ. Seroprevalencia de anticuerpos frente a la borreliosis de Lyme en población sana de la isla de Lanzarote. Med Clín (Barc) 1995; 104:38.
33. García-Moncó JC. Diagnóstico de la enfermedad de Lyme. Med Clín (Barc) 1991; 96:544-548.
34. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392-400.
35. Sadziene A, Thompson PA, Barbour AG. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis 1993; 167:165-172.
36. Oteo JA, Martínez de Artola V, Casas JM, Estrada Peña A. Enfermedad de Lyme en La Rioja. Med Clín (Barc) 1991; 96:599.
37. Asensi M, Martínez AM, Guerrero A, et al. Estudio epidemiológico de la enfermedad de Lyme en Asturias. Enferm Infecc Microbiol Clin 1993; 11:420-423.
38. Nuti M, Amaddeo D, Crovatto M, et al. Infections in Alpine environment: antibodies to hantaviruses, leptospira, rickettsiae and Borrelia burgdorferi in defined Italian populations. Am J Trop Med Hyg 1993; 48:20-25.
39. Fahrer H, Van der Linden SM, Sauvain MJ, Gern L, Zhioua E, Aeschlimann A. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Inf Dis 1991; 163:305-310.
40. De Marval F, Gern L, Aeschlimann A. Seroepidemiological studies on Lyme borreliosis in two populations exposed to tick bites. IV International Conference of Lyme Borreliosis. Bolonia, Italia. 1994.
41. Blaauw I, Nohlmans L, Van den Bogaard T, Van der Linden S. Diagnostic tools in Lyme borreliosis: clinical history compared with serology. J Clin Epidemiol 1992; 11:1.229-1.236.
42. Nadal D, Wunderli W, Briner H, Hansen K. Prevalence of antibodies to Borrelia burgdorferi in forestry workers and blood donnors from the same region in Switzerland. Eur J Clin Infect Dis 1989; 8:992-995.
43. Münchhoff P, Wilske B, Preac-Mursic V, Schierz G. Antibodies against Borrelia burgdorferi in Bavarian forest workers. Zbl Bakt Hyg 1986; 263:412-419.
44. López Prieto MD, Borobio MV. Prevalencia de anticuerpos frente a Borrelia burgdorferi en la provincia de Sevilla. Enferm Infecc Microbiol Clin 1989; 7:489-490.
45. Gustafson R, Svenungsson B, Gardulf A, Stiernsted G, Forsgren M. Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population. Scand J Infect Dis 1990; 22:297-306.
46. Oteo JA, Backenson PB, Vitutia MM, García-Moncó JC, Rodríguez I, Escudero R, Anda P. Use of the C3H/He Lyme disease mouse model for the recovery of Borrelia garinii from erithema migrans lesions. Res Microbiol 1998; 149:39-46.
47. Le Fleche A, Postic D, Girardet K, Peter K, Peter O, Baranton G. Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequene analysis. Int J Syst Bacteriol 1997; 47:921-925.
48. Wang G, Van Dam AP, Le Fleche A, et al. Genetic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacteriol 1997; 47:926-932.
49. Arzouni JP, Laveran M, Beytut J, Ramousse O, Raoult D. Comparison of western blot and microimmunofluorescence as tools for Lyme disease seroepidemiology. Eur J Epidemiol 1993; 3:269-273.
50. Baird AG, Gillies JCM, Bone FJ, Dale BAS, Miscampbell NT. Prevalence of antibody indicating Lyme disease in farmers in Wigtownshire. Br Med J 1989; 299:836-837.
51. Morgan-Capner P, Cutler SJ, Wright DJM. Borrelia burgdorferi infection in UK forestry workers at risk of tick bites. Lancet 1989; i:789.
52. Doby JM, Couatarmanacth A, Farges J, Chevrier S. Les espirochetosés à tique chez les professionals de la forêt. Enquête sérologique chez 653 sujets de 10 départements de l'ouest de la France. Arch Mal Prol 1989; 50:751-757.
53. Guy EC, Bateman DE, Martyn CN, Heckels JE. Lyme disease prevalence and clinical importance of Borrelia burgdorferi specific IgG in forestry workers. Lancet 1989; i:484-486.
54. Kuiper H, De Jongh BM, Nauta AP, et al. Lyme borreliosis in Dutch forestry workers. J Infect 1991; 3:279-286.
55. Neubert U, Münchhoff P, Völker B, Reimers CD, Pflüger KH. Borrelia burgdorferi infections in Bavarian forest workers. Ann NY Acad Sci 1988; 539:476-479.
56. Zivanovic B, Ler Z, Cekanac R. Rizik od infekcije Borelijom burgdorferi u endemskom producju lajmske bolesti. (Risk of infection with Borrelia burgdorferi in an area endemic for Lyme disease). Vojnosanit Pregl 1991; 5:400-404.
57. Guerrero A, Quereda C, Marti-Belda P, Escudero R. Borreliosis de Lyme, ¿cómo se manifiesta en España? Med Clin (Barc) 1993, 101:5-7.
58. Hamlet N, Natwani D, Ho-Yen DO, Walker E. Borrelia burgdorferi infection in UK forestry workers at risk of tick bites. Lancet 1989; i:789-790.
59. Vos K, Van Damm AP, Kuiper H, Bruins H, Spanjaard L, Dankert J. Seroconversion for Lyme borreliosis among Dutch military. Scand J Infect Dis 1994; 26:427-434.
60. Aeschlimann A, Gern L, Zhioua E, et al. Observations of two high-risk populations from the Swiss Plateau, a region heavily infested with Ixodes ricinus/Borrelia burgdorferi complex. Ann NY Acad Sci 1987; 539:440-443.
61. Schmidt R, Kabatzki J, Hartung S, Ackermann R. Erythema chronicum migrans disease in the Federal Republic of Germany. Zbl Bakt Hyg 1986; 263:435-441.
62. De Mik EL, Van Pelt W, Van Leeuwen BD, Van der Veen A, Schellekens JF, Borgdorff MW. The geographical distribution of tick bites and erythema migrans in general practice in The Netherlands. Int J Epidemiol 1997; 2:451-457.
63. Steere AC, Broderick TE, Malawista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol 1978; 108:312-321.
64. Cimmino MA, Fumarola D. The risk of Borrelia burgdorferi infection is not increased in pet owners. JAMA 1989; 262:2.997-2.998.
65. Curran KL, Fish D. Increased risk of Lyme disease for cat owners. N Eng J Med 1989; 320:183.
66. Aeschlimann A, Chamot E, Gigon F, Jeanneret JP, Kesseler D, Walther C. Borrelia burgdorferi in Switzerland. Zbl Bakt Hyg 1986; 263:450-458.
67. Schwartz BS, Ford DP, Childs JE, Rothman N, Thomas RJ. Anti-tick saliva antibody: a biologic marker of tick exposure that is a risk factor for Lyme disease seropositive. Am J Epidemiol 1991; 1:86-95